Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Drug Targets|February 20, 2007
In vivo osteoarthritis target validation utilizing genetically-modified miceSonya S GlassonILAR Journal|October 14, 2008
The influence of enrichment devices on development of osteoarthritis in a surgically induced murine modelAlba Salvarrey-Strati, Lyna Watson, Tracey Blanchet, et al.The American Journal of Sports Medicine|February 22, 2005
Chondral defect repair after the microfracture procedure: a nonhuman primate modelThomas J Gill, Patrick C McCulloch, Sonya S Glasson, et al.BMC Musculoskeletal Disorders|July 19, 2011
Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilageLisha Patel, Weiyong Sun, Sonya S Glasson, et al.Arthritis and Rheumatism|October 31, 2007
Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritisManas K Majumdar, Roger Askew, Scott Schelling, et al.Nature|April 1, 2005
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritisSonya S Glasson, Roger Askew, Barbara Sheppard, et al.Arthritis and Rheumatism|August 31, 2004
Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout miceSonya S Glasson, Roger Askew, Barbara Sheppard, et al.Arthritis and Rheumatism|February 28, 2009
Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricinCarl R Flannery, Richard Zollner, Chris Corcoran, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis modelNing Li, Moisés A Rivéra-Bermúdez, Mei Zhang, et al.Pageof 1